Liraglutide - Next-Generation Antidiabetic Medication

Novo Nordisk’s NovoMix 30 is a unique insulin analogue that combines rapid and intermediate acting insulin aspart, providing the insulin requirement in a single injection.

| 1 | 2 | 3 | 4 |

Browse More Images - Return to Project